Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...

The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

It operates a logistics and delivery arm, a digital entertainment business, and perhaps most important, a cloud computing division that's also waist-deep into artificial intelligence ... Most ...

U.S. equities rebounded strongly in Q2, with growth stocks and mid-caps leading gains; our portfolio outperformed via IT, ...

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...